Skip to main content
Journal cover image

Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin

Publication ,  Journal Article
Celik, H; Wakim, P; Pritchard, WF; Castro, M; Leonard, S; Karanian, JW; Dewhirst, MW; Lencioni, R; Wood, BJ
Published in: JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
December 1, 2019

Duke Scholars

Published In

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

DOI

EISSN

1535-7732

ISSN

1051-0443

Publication Date

December 1, 2019

Volume

30

Issue

12

Start / End Page

1908 / 1914

Publisher

ELSEVIER SCIENCE INC

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Celik, H., Wakim, P., Pritchard, W. F., Castro, M., Leonard, S., Karanian, J. W., … Wood, B. J. (2019). Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 30(12), 1908–1914. https://doi.org/10.1016/i.jvir.2019.04.023
Celik, Haydar, Paul Wakim, William F. Pritchard, Meryll Castro, Shelby Leonard, John W. Karanian, Mark W. Dewhirst, Riccardo Lencioni, and Bradford J. Wood. “Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.” JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY 30, no. 12 (December 1, 2019): 1908–14. https://doi.org/10.1016/i.jvir.2019.04.023.
Celik H, Wakim P, Pritchard WF, Castro M, Leonard S, Karanian JW, et al. Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. 2019 Dec 1;30(12):1908–14.
Celik, Haydar, et al. “Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.” JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, vol. 30, no. 12, ELSEVIER SCIENCE INC, Dec. 2019, pp. 1908–14. Wos, doi:10.1016/i.jvir.2019.04.023.
Celik H, Wakim P, Pritchard WF, Castro M, Leonard S, Karanian JW, Dewhirst MW, Lencioni R, Wood BJ. Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY. ELSEVIER SCIENCE INC; 2019 Dec 1;30(12):1908–1914.
Journal cover image

Published In

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

DOI

EISSN

1535-7732

ISSN

1051-0443

Publication Date

December 1, 2019

Volume

30

Issue

12

Start / End Page

1908 / 1914

Publisher

ELSEVIER SCIENCE INC

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • 3202 Clinical sciences
  • 1103 Clinical Sciences